Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676904 · ClinicalTrials.gov registry record · NA
Neonatal Platelet Transfusion Threshold Trial
A NA study of Thrombosis and Thrombocytopenia, sponsored by NICHD Neonatal Research Network.
- Recruiting
- Registry status
- NA
- Development phase
- 2,433
- Enrollment target
- 20
- Study locations
NCT06676904 is a NA study of Thrombosis and Thrombocytopenia that is actively recruiting participants, run by NICHD Neonatal Research Network. The registered enrollment target is 2,433 participants, above the 383-participant average among 28 other Thrombosis trials with a reported enrollment target (535% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT06676904, a NA study of Thrombosis and Thrombocytopenia, is actively recruiting participants, sponsored by NICHD Neonatal Research Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,433 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
Conditions Studied
Interventions
- PROCEDURE Higher Platelet Transfusion Threshold
- PROCEDURE Lower Platelet Transfusion Threshold
Study Locations (20)
Ohio
- Cincinnati Children's Medical Center - Cincinnati
- Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland
- Nationwide Children's Hospital - Columbus
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
- University of Texas Health Science Center at Houston - Houston
- Pediatrix Medical Group - San Antonio
California
- Stanford University - Palo Alto
- Sharp Mary Birch Hospital for Women & Newborns - San Diego
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado - Aurora
Georgia
- Emory University - Atlanta
Illinois
- Northwestern Lurie Children's Hospital of Chicago - Chicago
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,433 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2031-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06676904
The ClinicalTrials.gov registry entry for NCT06676904 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,433 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 383-participant average among 28 other Thrombosis trials with a reported enrollment target (535% higher). The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which Higher Platelet Transfusion Threshold is the first listed.
NCT06676904 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Ohio, Texas, California.
Frequently Asked Questions
What is clinical trial NCT06676904 about?
NCT06676904 is a clinical study titled "Neonatal Platelet Transfusion Threshold Trial". The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
What is the current status of trial NCT06676904?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,433 participants. The study started on 2025-06-13. Estimated completion is 2031-04-30.
What conditions does trial NCT06676904 study?
This clinical trial studies the following conditions: Thrombosis, Thrombocytopenia, Infant, Small for Gestational Age, Infant, Newborn, Diseases, Neonatal.
What interventions are being tested in trial NCT06676904?
The interventions under investigation include: Higher Platelet Transfusion Threshold (PROCEDURE), Lower Platelet Transfusion Threshold (PROCEDURE).
Who is sponsoring clinical trial NCT06676904?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06676904 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
COMPLETED · NA
-
PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
COMPLETED · NA
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.